Prothena Corporation plc
News
Zurcher Kantonalbank Zurich Cantonalbank Acquires 1,186 Shares of Prothena Co. plc (NASDAQ:PRTA)
Ticker Report Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Prothena Co. plc (NASDAQ:PRTA - Free Report) by 13.1% during the second quarter, according to the company in its most recent...\n more…
Signaturefd LLC Raises Stake in Prothena Co. plc (NASDAQ:PRTA)
Ticker Report Signaturefd LLC boosted its holdings in shares of Prothena Co. plc (NASDAQ:PRTA - Free Report) by 182.1% during the 2nd quarter, HoldingsChannel reports. The firm owned 1,337 shares of the...\n more…
Prothena Co. plc (NASDAQ:PRTA) Receives $62.86 Consensus Price Target from Analysts
Ticker Report Prothena Co. plc (NASDAQ:PRTA - Get Free Report) has received an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the firm, Marketbeat reports. Two investment...\n more…
Prothena to Participate in Upcoming Healthcare Conferences
Business Wire Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced...\n more…
What Makes Prothena (PRTA) a New Buy Stock
Zacks Investment Research Prothena (PRTA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of...\n more…
Prothena (NASDAQ:PRTA) Given New $62.00 Price Target at Oppenheimer
Ticker Report Prothena (NASDAQ:PRTA - Free Report) had its target price decreased by Oppenheimer from $66.00 to $62.00 in a report released on Wednesday, Benzinga reports. Oppenheimer currently has an outperform...\n more…